Brojde - Researchers

Researchers

Goulnar Kasymjanova MD

Tasnim Daginawala, research coordinator

Goulnar Kasymjanova MD

Goulnar's role in the program is to support, initiate and conduct research projects relevant to the program and its effects on patients and families.

Position 

  • Oncology Researcher

Education 

  • Medical Degree, State University of Medicine, Almaty Kazakhstan

Recent Publications 

  • Smith BM, Schwartzman K, Kovacina B, Taylor J, Kasymjanova G, Brandao G, Agulnik J S.: Lung cancer histologies associated with emphysema on computed tomography. Lung Cancer 76:61-6, 2012
  • Kasymjanova G, Macdonald N, Agulnik J S, Cohen V, Pepe C, Kreisman H, Sharma R, and Small D. The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer. Current oncology (Toronto, Ont.17:52-58, 2010
  • Cohen V, Agulnik J S, Ang C, Kasymjanova G, Batist G, Small D, Brandao G, Chong G, and Miller W H, Jr. Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer: impact on response to therapy with epidermal growth factor receptor-tyrosine kinase inhibitors. Cancer.116:4309-4317, 2010
  • Gagnon B, Abrahamowicz M, Xiao Y, Beauchamp M E, MacDonald N, Kasymjanova G, Kreisman H, and Small D. Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer. Br J Cancer.102:1113-1122, 2010

Research Activities: 

Clinical trials:

  • Feasibility questionnaires
  • Submission
  • Amendments
  • Renewals

Academic research (current):

  • EGFR project 
  • Utility of non-surgical biopsies in the genetic profiling of non-small cell lung cancer
  • TKI response correlation with biological response in advanced NSCLC
  • Cluster analysis of prognostic factors in early stage NSCLC
  • Prognostication in advanced lung cancer 
  • First line TKI treatment

Tasnim Daginawala, research coordinator

 

 

 

Page last updated on 

We always seek feedback to make our site better.